2A60.2

ICD-11 MMS 2026-01

Therapy-related myeloid neoplasms

Inclusions

  • therapy-related myelodysplastic syndromes

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Child codes

  • 2A60.20 – Therapy related acute myeloid leukaemia or myelodysplastic syndrome
  • 2A60.2Y – Other specified therapy-related myeloid neoplasms
  • 2A60.2Z – Therapy-related myeloid neoplasms, unspecified

Sibling codes

  • 2A60.0 – Acute myeloid leukaemia with recurrent genetic abnormalities
  • 2A60.1 – Acute myeloid leukaemia with myelodysplasia-related changes
  • 2A60.3 – Acute myeloid leukaemia, not elsewhere classified by criteria of other types
  • 2A60.4 – Myeloid proliferation associated with Down syndrome
  • 2A60.5 – Blastic plasmacytoid dendritic cell neoplasm
  • 2A60.Y – Other specified acute myeloid leukaemias and related precursor neoplasms
  • 2A60.Z – Acute myeloid leukaemias and related precursor neoplasms, unspecified

Foundation entity

Therapy-related myeloid neoplasms – http://id.who.int/icd/entity/1738843761

Allowed postcoordination axes

Part of: 2A60: Acute myeloid leukaemias and related precursor neoplasms › 02: Neoplasms